-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, OxbO16Zu21bScIbVD3+GFpRB1H3eBCRVpTwbkcr7SXdiCOiR0QB2+S5quIS3HyNV fSZEGof2XWjO4t8D022cBg== 0000929624-00-000090.txt : 20000204 0000929624-00-000090.hdr.sgml : 20000204 ACCESSION NUMBER: 0000929624-00-000090 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20000203 GROUP MEMBERS: ANSELM LEUNG GROUP MEMBERS: BIOASIA INVESTMENTS LLC GROUP MEMBERS: BIOTECHNOLOGY DEVELOPMENT FUND, L.P. GROUP MEMBERS: EDGAR ENGLEMAN GROUP MEMBERS: FRANK KUNG SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: INKINE PHARMACEUTICAL CO INC CENTRAL INDEX KEY: 0000929547 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133754005 STATE OF INCORPORATION: NY FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: SEC FILE NUMBER: 005-47845 FILM NUMBER: 520896 BUSINESS ADDRESS: STREET 1: 1720 WALTON RD STREET 2: SUITE 200 CITY: BLUE BELL STATE: PA ZIP: 19422 BUSINESS PHONE: 6102609350 MAIL ADDRESS: STREET 1: 1720 WALTON RD STREET 2: SUITE 200 CITY: BLUE BELL STATE: PA ZIP: 19422 FORMER COMPANY: FORMER CONFORMED NAME: PANAX PHARMACEUTICAL CO LTD DATE OF NAME CHANGE: 19940906 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: BIOASIA INVESTMENTS LLC CENTRAL INDEX KEY: 0001103307 STANDARD INDUSTRIAL CLASSIFICATION: [] STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 575 HIGH STREET SUITE 201 CITY: PALO ALTO STATE: CA ZIP: 94301 BUSINESS PHONE: 6506880821 MAIL ADDRESS: STREET 1: 575 HIGH STREET STE 201 CITY: PALO ALTO STATE: CA ZIP: 94301 SC 13G/A 1 SCHEDULE 13-D, FINAL AMENDMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (FINAL AMENDMENT)* InKine Pharmaceutical Company, Inc. --------------------------------------------------------------------- (Name of Issuer) Common Stock ---------------------------------------------------------- (Title of Class of Securities) 69830P105 ---------------------------------------------------- (CUSIP Number) Check the following box if a fee is being paid with this statement [_]. (A fee is not required only if the filing person: (1) has a previous statement on file reporting beneficial ownership of more than five percent of the class of securities described in Item 1; and (2) has filed no amendment subsequent thereto reporting beneficial ownership of five percent or less of such class.) (See Rule 13d-7). *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act. Page 1 of 8 Pages - -------------------------------------------------------------------------------- NAME OF REPORTING PERSON 1 S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Biotechnology Development Fund, L.P. ("BDF") 94-3258409 - -------------------------------------------------------------------------------- CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* 2 (a) [_] (b) [X] - -------------------------------------------------------------------------------- SEC USE ONLY 3 - -------------------------------------------------------------------------------- CITIZENSHIP OR PLACE OF ORGANIZATION 4 Delaware - -------------------------------------------------------------------------------- SOLE VOTING POWER 5 NUMBER OF 431,960 shares, except that BioAsia, the general partner SHARES BDF, and Kung, Leung and Engleman, members of BioAsia, BENEFICIALLY may be deemed to have shared power to vote these shares. OWNED BY EACH ------------------------------------------------------------- REPORTING SHARED VOTING POWER PERSON 6 WITH See response to item 5. ------------------------------------------------------------- SOLE DISPOSITIVE POWER 7 431,960 shares, except that BioAsia, the general partner BDF, and Kung, Leung and Engleman, members of BioAsia, may be deemed to have shared power to dispose of these shares. -------------------------------------------------------------- SHARED DISPOSITIVE POWER 8 See response to item 7. - -------------------------------------------------------------------------------- AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 9 431,960 - -------------------------------------------------------------------------------- CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* 10 N.A. - -------------------------------------------------------------------------------- PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 11 1.68% - -------------------------------------------------------------------------------- TYPE OF REPORTING PERSON* 12 PN - -------------------------------------------------------------------------------- Page 2 of 8 pages - -------------------------------------------------------------------------------- NAME OF REPORTING PERSON 1 S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON BioAsia Invesments, LLC ("BioAsia") 94-3258407 - -------------------------------------------------------------------------------- CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* 2 (a) [_] (b) [X] - -------------------------------------------------------------------------------- SEC USE ONLY 3 - -------------------------------------------------------------------------------- CITIZENSHIP OR PLACE OF ORGANIZATION 4 California - -------------------------------------------------------------------------------- SOLE VOTING POWER 5 NUMBER OF 0 SHARES BENEFICIALLY OWNED BY EACH ----------------------------------------------------------- REPORTING SHARED VOTING POWER PERSON 6 WITH 431,960 shares, all of which are directly owned by BDF. BioAsia is the general partner of BDF and may be deemed to have shared power to vote these shares. ----------------------------------------------------------- SOLE DISPOSITIVE POWER 7 0 ----------------------------------------------------------- SHARED DISPOSITIVE POWER 8 431,960 shares, all of which are directly owned by BDF. BioAsia is the general partner of BDF and may be deemed to have shared power to dispose of these shares. - -------------------------------------------------------------------------------- AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 9 431,960 - -------------------------------------------------------------------------------- CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* 10 N.A. - -------------------------------------------------------------------------------- PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 11 1.68% - -------------------------------------------------------------------------------- TYPE OF REPORTING PERSON* 12 PN - -------------------------------------------------------------------------------- Page 3 of 8 pages - -------------------------------------------------------------------------------- NAME OF REPORTING PERSON 1 S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Frank Kung ("Kung") ###-##-#### - -------------------------------------------------------------------------------- CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* 2 (a) [_] (b) [X] - -------------------------------------------------------------------------------- SEC USE ONLY 3 - -------------------------------------------------------------------------------- CITIZENSHIP OR PLACE OF ORGANIZATION 4 United States - -------------------------------------------------------------------------------- SOLE VOTING POWER 5 NUMBER OF 0 SHARES BENEFICIALLY OWNED BY EACH ----------------------------------------------------------- REPORTING SHARED VOTING POWER PERSON 6 WITH 431,960 shares, all of which are directly owned by BDF. Kung is a member of BioAsia and may be deemed to have shared power to vote these shares. ----------------------------------------------------------- SOLE DISPOSITIVE POWER 7 0 ----------------------------------------------------------- SHARED DISPOSITIVE POWER 8 431,960 shares, all of which are directly owned by BDF. Kung is a member of BioAsia and may be deemed to have shared power to dispose of these shares. - -------------------------------------------------------------------------------- AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 9 431,960 - -------------------------------------------------------------------------------- CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* 10 N.A. - -------------------------------------------------------------------------------- PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 11 1.68% - -------------------------------------------------------------------------------- TYPE OF REPORTING PERSON* 12 IN - -------------------------------------------------------------------------------- Page 4 of 8 pages - -------------------------------------------------------------------------------- NAME OF REPORTING PERSON 1 S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Anselm Leung ("Leung") ###-##-#### - -------------------------------------------------------------------------------- CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* 2 (a) [_] (b) [X] - -------------------------------------------------------------------------------- SEC USE ONLY 3 - -------------------------------------------------------------------------------- CITIZENSHIP OR PLACE OF ORGANIZATION 4 United States - -------------------------------------------------------------------------------- SOLE VOTING POWER 5 NUMBER OF 0 SHARES BENEFICIALLY OWNED BY EACH ----------------------------------------------------------- REPORTING SHARED VOTING POWER PERSON 6 WITH 431,960 shares, all of which are directly owned by BDF. Leung is a member of BioAsia and may be deemed to have shared power to vote these shares. ----------------------------------------------------------- SOLE DISPOSITIVE POWER 7 0 ----------------------------------------------------------- SHARED DISPOSITIVE POWER 8 431,960 shares, all of which are directly owned by BDF. Leung is a member of BioAsia and may be deemed to have shared power to dispose of these shares. - -------------------------------------------------------------------------------- AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 9 431,960 - -------------------------------------------------------------------------------- CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* 10 N.A. - -------------------------------------------------------------------------------- PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 11 1.68% - -------------------------------------------------------------------------------- TYPE OF REPORTING PERSON* 12 IN - -------------------------------------------------------------------------------- Page 5 of 8 pages - -------------------------------------------------------------------------------- NAME OF REPORTING PERSON 1 S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Edgar Engleman ("Engleman") ###-##-#### - -------------------------------------------------------------------------------- CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* 2 (a) [_] (b) [X] - -------------------------------------------------------------------------------- SEC USE ONLY 3 - -------------------------------------------------------------------------------- CITIZENSHIP OR PLACE OF ORGANIZATION 4 United States - -------------------------------------------------------------------------------- SOLE VOTING POWER 5 NUMBER OF 0 SHARES BENEFICIALLY OWNED BY EACH ----------------------------------------------------------- REPORTING SHARED VOTING POWER PERSON 6 WITH 431,960 shares, all of which are directly owned by BDF. Engleman is a member of BioAsia and may be deemed to have shared power to vote these shares. ----------------------------------------------------------- SOLE DISPOSITIVE POWER 7 0 ----------------------------------------------------------- SHARED DISPOSITIVE POWER 8 431,960 shares, all of which are directly owned by BDF. Engleman is a member of BioAsia and may be deemed to have shared power to dispose of these shares. - -------------------------------------------------------------------------------- AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 9 431,960 - -------------------------------------------------------------------------------- CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* 10 N.A. - -------------------------------------------------------------------------------- PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 11 1.68% - -------------------------------------------------------------------------------- TYPE OF REPORTING PERSON* 12 IN - -------------------------------------------------------------------------------- Page 6 of 8 pages Biotechnology Development Fund, L.P., a Delaware limited partnership ("BDF") BioAsia Investments, LLC, a California limited liability company ("BioAsia"), Frank Kung ("Kung"), Anselm Leung ("Leung") and Edgar Engleman ("Engleman")(BDF, BioAsia, Kung, Leung and Engleman are each a Reporting Person), hereby amend the single joint statement on Schedule 13G, filed with the Securities and Exchange Commission, with respect to certain shares of common stock, $0.0001 par value per share (the "Common Stock"), of InKine Pharmaceutical Company, Inc., a New York corporation (the "Issuer"), as follows: Item 4. Ownership (a) Amount Beneficially Owned: See Row 9 of cover page for each Reporting Person. (b) Percent of Class: See Row 11 of cover page for each Reporting Person. (c) Number of shares as to which such person has: (i) sole power to vote or to direct the vote: See Row 5 of cover page for each Reporting Person. (ii) shared power to vote or to direct the vote: See Row 6 of cover page for each Reporting Person. (iii) sole power to dispose or to direct the disposition of: See Row 7 of cover page for each Reporting Person. (iv) shared power to dispose or to direct the disposition of: Item 10. Certification By signing below I certify that, to the best of my knowledge and belief, that the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. Page 7 of 8 pages SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: January 31, 2000 Biotechnology Development Fund, L.P, By: BioAsia Investments, LLC Its: General Partner By: /s/Frank Kung ----------------------- Frank Kung, Member BioAsia Investments, LLC By: /s/Frank Kung ------------------------------- Frank Kung, Member /s/Frank Kung ------------------------------------- Frank Kung /s/Anselm Leung ------------------------------------- Anselm Leung /s/Edgar Engleman ------------------------------------- Edgar Engleman ATTENTION: INTENTIONAL MISSTATEMENTS OR OMISSIONS OF FACT CONSTITUTE FEDERAL CRIMINAL VIOLATIONS (SEE 18 U.S.C. 1001) Page 8 of 8 pages -----END PRIVACY-ENHANCED MESSAGE-----